However, the negative correlation with CD8+ T cells may indicate that in some cases, the increased expression or activity of AKR1B10 may inhibit the function or number of CD8+ T cells, and thus lead to the weakened immune response of the immune system to infection and tumor. Here, CD8A is linked to neoplasm.